Testing a scanner to check cancer removal during breast surgery
Part of Cancer, Skin clinical trials.
This study tests a new scanner that helps doctors see if all the breast cancer was removed during surgery, right there in the operating room. It may help reduce the chance of needing a second surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with breast cancer through a biopsy.
- Your care team has decided that breast-conserving surgery (lumpectomy) is right for you.
- You are having your surgery at Silesian Hospital in Opava during this study period.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a scanner that checks removed breast tissue during surgery to help surgeons remove all cancer the first time. If it works, fewer women may need a second operation.
This study tests a new imaging tool that helps surgeons see if any cancer cells are left behind during a lumpectomy. It may reduce the need for a second surgery.
This trial looks at different methods doctors can use to locate a breast lesion using imaging, so it can be removed accurately during breast-conserving surgery. It may help your care team choose the best localization approach for your type and location of lesion.
This trial tests a device called OneMark that helps doctors find and track breast cancer during surgery and follow-up. It may help make sure the cancer is removed completely.
This trial tests a new technology that helps doctors examine cells during surgery for early-stage breast cancer. It may help make the sentinel lymph node biopsy more accurate.
This trial studies a new method (SAVI Scout) to help surgeons locate and remove breast tumors more precisely during surgery. It may reduce the need for multiple markers and improve outcomes.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.